Jazz Pharmaceuticals plc annual gross profit for fiscal 2025 was $3.8 billion, an increase of 3.9% from $3.6 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gross Profit | $3.8B | $3.6B | $3.4B | $3.1B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit | $935M | $1.0B | $997M | $929M | $793M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More JAZZ metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All JAZZ financial statements → Interactive JAZZ charts →
About TickerBase · Data methodology & sources